Your solution

Neostigmine Methylsulfate

CAS: 51-60-5

Back to results
Neostigmine Methylsulfate
Neostigmine methylsulfate, a cholinesterase inhibitor, is indicated for reversal of the effects of non-depolarizing neuromuscular blocking agents (NMBAs, like Vecuronium or Rocuronium bromide) after surgery. Neostigmine is on the World Health Organization model list of essential medicines.

Therapeutic group
Other nervous system drugs, anticholinesterases
ATC codes: N07AA01, N07AA51 (combinations)
Your selection
Request factsheet Request technical support
Neostigmine Methylsulfate

Key dosage forms

  • Injectable solution (0.5 mg/mL)
  • Injectable solution (1 mg/mL)

Features

  • Reliable partner
  • Complete documentation
  • Full regulatory support
  • Short lead time
  • Worldwide exclusivity

Some brand names

  • BLOXIVERZ® (EXELA, formerly AVADEL)
  • PROSTIGMIN(E)® (BAUSCH HEALTH, MEDA)

How can we support you with Neostigmine Methylsulfate?

I am looking for..
Creating a world of opportunity

This website uses cookies to improve your user experience

We use cookies for a variety of purposes, such as website functionality and helping target our marketing activities. Click "accept" to accept our cookies. You can change the cookie settings by clicking "change settings".